Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 7 July 2000:
Vol. 289. no. 5476, pp. 37 - 39
DOI: 10.1126/science.289.5476.37
Prev | Table of Contents | Next

News Focus

BIOMEDICINE:
New Insights Into Type 2 Diabetes

Joe Alper

Researchers studying type 2 diabetes are optimistic that they are closing in on the elusive causes of the world's most prevalent metabolic disorder--although no one is willing to bet the bank on it. Using both biochemical and genetic approaches, diabetes researchers have identified multiple intracellular signaling pathways that appear to lie at the heart of this condition, which affects some 250 million people worldwide and is the leading cause of blindness, kidney failure, and amputation among adults. And in the process, they have thrown out much of the dogma of the past 10 years.

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Contributions of Insulin-Resistance and Insulin-Secretory Defects to the Pathogenesis of Type 2 Diabetes Mellitus.
J. E. Gerich (2003)
Mayo Clin. Proc. 78, 447-456
   Abstract »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)